Abstract
Background
The large conductance calcium-activated potassium channel alpha-subunit (Slo) is widely distributed throughout the body and plays an important role in a number of diseases. Prior work has shown that Slo, through its S10 region, interacts with β-catenin, a key component of the cytoskeleton framework and the Wnt signaling pathway. However, the physiological significance of this interaction was not clear.
Methodology/Principal Findings
Using a combination of proteomic and cell biology tools we show the existence of additional multiple binding sites in Slo, and explore in detail β-catenin interactions with the S10 region. We demonstrate that deletion of this region reduces Slo surface expression in HEK cells, which indicates that interaction with beta-catenin is important for Slo surface expression. This is confirmed by reduced expression of Slo in HEK cells and chicken (Gallus gallus domesticus leghorn white) hair cells treated with siRNA to β-catenin. HSlo reciprocally co-immunoprecipitates with β-catenin, indicating a stable binding between these two proteins, with the S10 deletion mutant having reduced binding with β-catenin. We also observed that mutations of the two putative GSK phosphorylation sites within the S10 region affect both the surface expression of Slo and the channel's voltage and calcium sensitivities. Interestingly, expression of exogenous Slo in HEK cells inhibits β-catenin-dependent canonical Wnt signaling.
Conclusions and Significance
These studies identify for the first time a central role for β-catenin in mediating Slo surface expression. Additionally we show that Slo overexpression can lead to downregulation of Wnt signaling.
Introduction
The large conductance Ca2+ activated potassium channel is a ubiquitous channel that plays numerous physiological roles [1] [2] [3]. Disordered channel function has been linked to diseases as diverse as hypertension, epilepsy and movement disorders. This channel is sensitive to changes in membrane voltage and intracellular Ca2+ concentrations [4]. It is also notable for its large single channel conductance ranging from 100–220 pS. The molecular identity of this channel was established by the cloning of the Drosophila homolog Slowpoke (Slo) [5]. The Slo protein consists of 6 transmembrane regions that are analogous to voltage activated potassium channels and a large intracellular C-terminus [5] [6]. The C-terminus contains the Ca2+ binding “bowl” together with the adjacent S10 region [5] [6]. It is now accepted that the core of this channel is formed by tetrameric association of alpha subunits encoded by this single gene [7].
The Slo protein associates with a number of ancillary subunits and other proteins that affect ion channel kinetics and subcellular localization [8]. The best studied among these subunits are the beta subunits 1–4, which affect both its kinetics and surface expression [9]. Cereblon is another protein that is important for the surface expression of Slo [10]. Other proteins that attach to Slo include Rack1 and cortactin, which mediate its interactions with protein kinase C and tyrosine kinases respectively [11] [12]. Caveolin-1 associates with Slo and may direct the channels to caveolae [13]. The ankyrin repeat protein ANKRA binds to Slo and affects its kinetics [14] . Syntaxin1 binds to Slo and decreases its voltage and apparent calcium sensitivities [15]. β-catenin was also identified as a Slo interacting protein [16].
β -catenin is a part of the cadherin cell adhesion complex and also mediates signaling by the Wnt pathway [17]. Work by Lesage et al., (2004) seeking to identify mechanisms of physically coupling Slo to voltage gated calcium channels (Cav), identified beta-catenin as interacting with Slo [16]. Previous work has shown beta-catenin interactions with Lin7/Velis/MALS, whose interaction partner Lin2/CASK also binds voltage-gated Ca2+ channels [18] [19] [20]. Lesage et al. performed a yeast two-hybrid screen using 467 amino acids of the intracellular C-terminus of Slo as bait. Three clones were identified, all of which encoded β-catenin. The authors went on to show that this interaction was mediated by the S10 region of Slo, and by the ninth armadillo repeat and a poorly defined region of the C-terminus distal to the ninth armadillo repeat in β-catenin. While they were able to demonstrate interactions between Slo and β-catenin in vivo by pull-down assays, they were unable to demonstrate a direct interaction between these proteins by heterologous expression in COS cells [16]. Thus, these authors established that Slo and β-catenin were associated, although the physiological significance of this interaction was unclear.
We present here data that extends this work. We demonstrate that the interaction between Slo and β-catenin is important for Slo surface expression in HEK-293 cells and chick hair cells in culture. Both deletion of the proposed S10 interacting region on HSlo and siRNA knockdown of β-catenin reduces Slo surface expression in HEK cells. Similarly, siRNA mediated knockdown of β-catenin resulted in decreased Slo on the surface of chick hair cells. Mutations of two putative GSK phosphorylation sites within the S10 region alter the surface expression of Slo in HEK cells, while also affecting the biophysical properties of the expressed channels. Since β-catenin is a major component in the Wnt signaling pathway, we also explored the effect of channel expression on Wnt signaling. Interestingly, expression of exogenous HSlo inhibits canonical Wnt signaling in HEK cells. This shows that Slo may modulate the Wnt signaling pathway presumably through its binding and immobilization of β-catenin.
Materials and Methods
Chemicals
Iberiotoxin-LC-Biotin was a kind gift from Dr. John-Paul Bingham (University of Hawaii). N-dodecyl beta-D-maltoside (DDM) was obtained from CalBiochem.
Antibodies
Antibody suppliers were as follows: mouse anti-Flag M2 and rabbit anti-Flag (Sigma); anti-BKCa (Alamone Labs); mouse β-catenin (BD Transduction Laboratories); mouse GSK3β (BD Transduction Laboratories); rabbit GSK3β (Cell Signaling); mouse anti-vinculin (Chemicon). bSloC was an affinity-purified rabbit antibody to the last C-terminal 21 amino acids of the bovine Slo channel.
Cell Lines and cell culture
HEK293 cells and H28 (NCI-H28) cells were from American Type Culture Collection (ATCC). 293T was a specially maintained cell line, which is responsive to stimulation of Wnt signaling [21]. HEK293 and 293T cells were grown in DMEM medium (Gibco) supplemented with 10% fetal bovine serum and 50 U/mL penicillin/streptomycin (Gibco), in a humidified incubator at 37°C with 5% CO2. Transfections were done using Lipofectamine 2000 (Invitrogen), or Superfect (Qiagen) according to manufacturers' instructions. The stable HSloHEK293 cell line used was described previously [22] . HSlo S10 deletion mutants and point mutants were stably transfected using G418 selection. HEK293-HSlo and mutant cells had 0.6 mg/mL Geneticin (G418, from Gibco) added for selective growth. H28 cells were grown in RPMI-1640 medium (Gibco) supplemented with 10% fetal bovine serum, 50 U/mL penicillin/streptomycin (Gibco). Reverse transfection was used for transfecting HSlo/EGFP in H28 cells.
Mutagenesis
A pcDNA3 vector encoding a His6-Flag-epitope tagged version of the human BK channel (HSlo) originally cloned by Wallner et al. (1995) was kindly supplied by Dr. Andrew Tinker, University College London [23]. The FLAG sequence was inserted at its extracellular N-terminus. The QuikChange II site-directed mutagenesis kit (Stratagene) was used to make deletion mutations and point mutations following the manufacturer's instructions. For the S10 deletion mutant the primer sequences were: forward primer 5′ctgtacctcacgcagcccaatgacaatatcctcaccctgatacgtac gctggtgacc 3′, backward primer 5′ggtcaccagcgtacgtatcagggtgaggatattgtcattgggctgc gtgaggtacag 3′. For S918A and S922A mutant the forward primer was 5′ gcatttgccgtcgctgtcctggacgctctcatgagcgctacgtacttca atg 3′, and the backward primer 5′cattgaagtacgtagcgctcatgagagcgtccaggacagcgacg gcaaatgc 3′.For S918D and S922D the forward primer was 5′ ggacagcatttgccgtcgacgtcctggacgatctcatgagcgcgacg 3′ and the backward primer 5′ cgtcgcgctcatgagatcgtccaggacgtcgacggcaaatgctgtcc 3′. The mutant inserts were sequenced in their entirety after mutagenesis. β-catenin-EGFP was subcloned from a LZRS-GFP-bCAT vector (a kind gift from Dr. Aimin Jiang, Department of Cell Biology, Yale School of Medicine) into pcDNA3.1_hygro(+) vector using BamHI/NotI restriction sites.
Immunofluorescence detection and FACS sorting
Surface labeling of HSlo/mutant in transfected HEK293 cells with Ibtx-LC-biotin was done as described previously [22]. For surface labeling of HSlo/mutants with anti-Flag antibody in HEK293 cells were grown in a 12-well culture plate on autoclaved cover slips treated with sterile poly-D-lysine hydrobromide (Sigma). Cells were washed twice with phosphate buffered saline pH 7.4 (PBS), and incubated in PBS containing 5% fetal bovine serum (FBS) (Gibco) and 5 µg/ml anti-Flag antibody for 1 hour at room temperature. Cells were washed three times in PBS and incubated for 40 minutes at room temperature in the same buffer containing 3 µg/ml secondary antibody-AlexaFluor conjugates (Molecular Probes). The cells were washed a further three times in PBS and fixed in 3% formaldehyde in PBS for 20 minutes before mounting. To label intracellular proteins cells were fixed after surface labeling for one hour. They were then permeabilized in 0.1% Triton X100 (Calbiochem) in PBS with 5% FBS, followed by intracellular labeling with antibodies.
Slo and β-catenin staining in hair cells was done as described previously [24]. β -catenin was labeled using TRITC conjugated anti β-catenin antibody (BD). BK channels were labeled using a mouse anti-Slo antibody (BD) that was detected in turn with an Alexa 647 conjugated anti-mouse antibody (Molecular Probes). Hair cells were imaged along the z axis at the same tonotopic location (3 mm from the apical end of the basilar papilla). We used Zeiss Image Examiner software to quantify fluorescence. Slo clusters were defined by fluorescence intensity. The minimal fluorescence intensity of Slo clusters (400 A.U.) were determined by random sampling of over 100 clusters from tall hair cells of control cochlea and cochlea treated with β-catenin siRNA and used as a cutoff to identify clusters. Immunofluorescence images were taken on a Zeiss LSM 510 or LSM-Meta Laser Scanning confocal microscope, or a Nikon Eclipse TE2000-E inverted epifluorescence microscope.
For FACS analysis cells were detached from culture dishes using Ca2+ free PBS, and HSlo surface expression detected as described above. FACS experiments were done as previously described on a FACS Caliber machine (BD BioSciences) using FlowJo software [25].
HSlo purification, western blotting and immunoprecipitation
HSlo was purified from a stable HSlo HEK cell membrane by affinity chromatography using an M2 anti-Flag/agarose (Sigma) column. Cells were lysed in 16 mM DDM, 250 mM KCl, protease inhibitor cocktail (Sigma). After washing with 20 column volumes of 16 mM DDM, 250 mM KCl, HSlo was eluted off the column with 100 µM Flag peptide (Sigma) in 16 mM DDM, 250 mM KCl. The eluate was separated on SDS-PAGE using 4–15% ReadyGel (BioRad), and protein detected with Gel-Blue staining solution (Pierce). For western blots, protein was wet transferred to PVDF membrane, blocked with PBS, 5% non-fat milk, 0.05% Tween-20 followed by incubation with the appropriate primary antibody in blocking solution. Blots were washed extensively in PBS, 0.05% Tween-20 before incubation with the appropriate secondary antibody. Secondary antibodies were matched with the corresponding primary antibody. These included bovine anti-goat IgG-HRP (mouse/human cross-adsorbed), donkey anti-rabbit IgG-HRP (mouse/human crossadsorbed), and chicken anti-mouse IgG-HRP (human cross-adsorbed) from Santa Cruz. Blots were again washed extensively in PBS, 0.05% Tween-20 before enhanced chemilluminescence (ECL) detection. WestDureUltra (Pierce) substrates were used for ECL detection.
siRNAs
In experiments using HEK cells siRNAs were transfected using Oligofectamine or RNAiMax (Invitrogen) at a final concentration of ∼80 nM total siRNAs. Paired plates of cells were transfected with siRNAs or buffer, then either stained live with anti-Flag/488 for surface protein or stained after fixation and permeabilization for total HSlo protein. Assays were done 48–72 hrs after transfection. Unless indicated otherwise, a combination of siRNAs against the same gene were used. siRNAs to HSlo and β-catenin were purchased from Qiagen and IDT. siRNA sequences to β-catenin (sense) are: 5′r(UGCUUGGUUCACCAGUGGAUU)3′and r(GGUGUAGAACACUAAUUAA)d(TT); siRNA sequences to HSlo (sense) are 5′r(GGGAUGUUACGUCAACCAU)D(TT)3′ AND 5′R(GGCGGAUGGCACUCUCAAA)d(TT)3′; siRNA sequences to β4 (sense) are 5′r(UUUCUGCUUGUACGUGACAUU)3′. In these experiments, cells were transfected using 40 nM of each siRNA, or 80 nM for β4.
In experiments on hair cells we used three siRNAs to chick β-catenin that had the following sequence: CTNNB1-1 CAACCAAGCAGGAGGGAAUUU (sense); CTNNB1-2 CAACAAGACAAAUGUGAAAUU (sense); CTNNB1-3 CCAUGGAGCCAGACAGAAAUU (sense). Here siRNA was transfected at a final concentration of 33.3 nm each (for a total concentration of 100 nM). In these experiments we used the x-TREMEGene SiRNA Transfection Reagent (Roche, Mannheim, Germany) as previously described [26]. Institutional Animal Care and Use Committee (IACUC) at Yale University specifically approved this study (protocol number 2010-10439 “Studies on Hair Cell BK Channels”).
TOPFLASH Luciferase Reporter Assay
HEK 293T cells grown in 12-well culture plates were transiently transfected with TOP-FLASH TCF reporter plasmid (0.2 µg), β-galactosidase expression vector (0.2 µg) and various expression plasmids as indicated for individual experiments. The total quantity of DNA (1.6 µg) added to each well for each of the transfection protocols was held constant by adding mock DNA (pcDNA3.1) where necessary. Cells were maintained in serum replete medium and then harvested 24–30 h post-transfection in 300 µl cell lysis buffer (Promega). Luciferase activity was determined using a luciferase assay system (Promega) and luminometer according to the manufacturer's specifications. β-galactosidase activity was measured at 420 nm using a spectrophotometer and was used to normalize for transfection efficiency. An aliquot from the cell lysates of each well were saved and used to determine protein expression of the transfected plasmids by Western blotting.
Electrophysiological recording
Macro-patch currents were obtained in the inside-out patch-clamp configuration [27] at room temperature from stable cell lines expressing HSlo and the different HSlo mutants. Patch pipettes (∼1 MΩ) were fabricated from borosilicate glass capillaries (WPI). Because of the high levels of HSlo expression, 21 nM Ibtx was included in the pipette to partially block the patch current I. Only records where the estimated maximum series resistance (Rs) voltage error RsI was less than 10 mV were used for analysis.
The pipette solution contained (in mM): 140 KCl, 20 KOH, 10 Hepes and 2 MgCl2 (pH 7.2). The bath solutions contained (in mM): 140 KCl, 20 KOH, 10 Hepes, 5 mM EGTA (for 0 Ca2+) or 5 mM HEGTA (for 10 µM Ca2+), and added CaCl2 to reach 10 µM free Ca2+ concentration (pH 7.2). The amount of CaCl2 needed to obtain 10 µM Ca2+ was calculated using Max Chelator (http://www.stanford.edu/~cpatton/downloads.htm). The desired free Ca2+ concentration was confirmed with a Ca2+-sensitive electrode (Orion electrode, Thermo Labsystems). Following initial recording in 0 µM Ca2+, currents were then recorded in 10 µM Ca2+ after fast perfusion exchange using a QMM perfusion tip (ALA Scientific Instruments). Activation time constants were determined by single exponential fitting of the traces following a 150 µs delay.
HSlo peptide array
HSlo peptide arrays were made by JPT Peptide Technologies (Berlin, Germany). Glass slides were spotted with individual peptides. Human and mouse IgG spots were used as controls and served to normalize fluorescence intensity between arrays. Purified GST-β-catenin in PBS was incubated with each triplicate array at a concentration of 1 µg/ml for 1 hour, followed by 3 washes in PBS. Bound GST- β-catenin was detected by 1∶1000 rabbit anti GST antibody followed by 3 washes in PBS, 0.05% Tween-20 and incubating with Alexa 546 conjugated goat anti-rabbit antibody (1∶5000). The slides were washed ×3 with PBS, 0.05% Tween-20 dried and fluorescence detected on a Genepix 4000B Microarray Scanner (Axon Instruments, CA). Fluorescence intensity was normalized to mouse IgG controls. A second triplicate set of arrays probed with GST alone and processed in an identical manner served to identify non-specific binding. Mean fluorescence data from each spot was averaged between the triplicate arrays. Mean fluorescence intensity for each peptide from arrays probed with GST alone was subtracted from corresponding data from arrays probed with GST- β-catenin to obtain an index of binding of β-catenin to each peptide. Fluorescence intensity was expressed in arbitrary units. We noted a range of values from 0–60,000 A.U. We considered a peptide to have true binding when it along with the two adjacent peptides had fluorescence intensity above 10,000 A.U.
Competitive HSlo binding to β-catenin
Cell lysates were made as in immuno-precipitation experiments. Slo peptides used for competitive binding were made by Biomatik (Canada). Peptide AchE is a 15mer fragment from acetylcholinesterase, used as a negative control. All peptides were dissolved to make 1 mg/ml stock solution, and used at a final working concentration of 100 µg/ml in peptide competitive binding assays. Briefly, 50 µl glutathione/agarose beads (from Pierce) were incubated with 1.5 µg of purified GST-tagged β-catenin (CTNNB1 from Abnova, Taiwan) in 0.5 ml wash buffer (same as IP wash buffer) for 30 min at 4°C. After washing, 20 µg of each peptide together with 0.2 ml HSlo HEK cell lysate (with fresh protease inhibitors added) was mixed with the β-catenin-bound beads, and incubated at 4°C over night. After extensive washing with wash buffer the bound HSlo- β-catenin was eluted by incubating with 50 µl 4× SDS sample buffer at room temperature for 30 min and collected by centrifugation. Western blotting, chemilluminescence detection, and densitometry measurement protocols were as described as in co-IP experiments.
Results
HSlo channels are distributed close to adhesion junctions, and colocalize with β-catenin on the surface of HEK cells
To study β-catenin-HSlo interactions we used an HSlo-HEK stable cell line, and ascertained the distribution of HSlo on the surface of these cells. We labeled Slo in these cells with a biotin-derivative of the highly specific BK channel blocker Iberiotoxin (Ibtx), which was in turn labeled with streptavidin-Alexa488 conjugate [22]. As shown in both the projected 3D reconstructions (Figure 1A) and orthogonal sections of confocal images (Figure 1B), there was a punctate pattern of surface labeling, concentrated near cell-cell junction in these cells. This pattern of staining was reminiscent of cell adhesion complexes, and suggested that this cell line could serve as a model system to study interactions between HSlo and β-catenin.
We then sought to determine if β-catenin colocalize with HSlo in these cells. Staining for the cell surface population of HSlo channels revealed sharp co-localization of these channels with β-catenin (Figure 1C).
HSlo S10 deletion mutants have decreased surface expression compared to wt HSlo
Previous experiments had shown that the S10 region is important for the interaction of Slo with β-catenin [16]. The S10 region, along with the adjacent “calcium bowl,” is highly conserved in Slo channels from Drosophila through humans suggesting that this region is critical to the normal functioning of this channel (Figure 2A and Figure S2). To further define the effects of S10, we made a deletion construct lacking the S10 region (HSloΔS10). We established a stable cell line with the construct in HEK cells and examined surface expression of HSlo. As shown in Figure 2, total HSlo decreased although HSlo on the surface of these cells decreased even further. In order to better quantify the changes in total Slo expression, we utilized fluorescence activated cell sorting (FACS). We ascertained surface expression of HSlo by labeling the FLAG tag at its extracellular N-terminus in non-permeabilized cells. Total expression of HSlo was determined by labeling the FLAG epitope after permeabilization. Figures 2H and I show that the relative surface expression of the deletion mutant decreased approximately 40% compared to wt Slo.
It should be noted that while the total expression of Slo in the deletion mutant was reduced, its expression pattern within the cell, was similar to the expression pattern of HSlo wt.
β-catenin knockdown decreases HSlo surface expression in stable HSlo-HEK cells
Since the S10 region is important for surface expression and since interaction of HSlo with β-catenin was thought to be mediated by the S10 region, we hypothesized that β-catenin was important for the surface expression of Slo through its interaction with Slo at the S10 region. We tested this hypothesis by knocking down the expression of β-catenin using siRNA, and then determining surface expression of HSlo in HEK cells. As shown in Figure 3, knocking down β-catenin with siRNA resulted in a decrease in the surface expression of HSlo (Figure 3C). As a control we used siRNA against the beta-4 subunit of chicken Slo (cSlo) which is not expressed in these cells. We noted no decrease in the surface expression of HSlo when transfected with siRNA to the chick β4 of the BK channel whose sequence has no homology in mammals. Also as a control we observed that siRNA to HSlo produced a marked decrease in the surface expression of HSlo. Again, we performed FACS experiments to quantify these effects. The ratio of surface to total HSlo decreased 29% in siRNA-β-catenin transfected cells compared to control transfection (Figure 3G). Interestingly, the transfection with β-catenin siRNA decreased the total amount of HSlo expressed in these cells, as detected by western blots of cell lysates (Figure 3E) and FACS using permeabilized cells. Moreover, we also detected more HSlo fragments in all the HSloΔS10-HEK cell lines compared to the wt HSlo (see Figure S1.). This suggests that interaction with β-catenin may be important in preventing HSlo degradation.
β-catenin knockdown decreases Slo clusters on the surface of chick hair cells
The initial rationale that led to the detection of interactions between Slo and β-catenin was to ascertain mechanisms that led to Slo localization at the basolateral surface of hair cells (along with voltage gated Ca2+ channels). We therefore sought to determine how β-catenin knockdown would affect Slo expression in hair cells. In these experiments we used chick hair cells in culture and knocked down β-catenin using siRNA transfection. As shown in Figure 4 there was a significant reduction in Slo expression in tall hair cells that receive afferent innervation. Total Slo expression was reduced 25% while β-catenin showed a 20% reduction. More importantly we noted a greater (70%) and statistically significant reduction of Slo clusters on the surface of hair cells after β-catenin knockdown. We have previously established that Slo channels exist as clusters on the basolateral surface of hair cell membranes [24]. Since almost all the Slo on the membrane of these cells are present in clusters, and since we did not observe Slo on the membrane independent of these clusters in siRNA treated cells, we cannot differentiate whether the effects on Slo clustering were due to decreased membrane targeting or effects on channel clustering.
In H28 β-catenin null cells, surface HSlo expression is stimulated by high-level exogenous β-catenin co-expression
We also tested the expression of HSlo in the β-catenin-deficient mesothelioma cell line H28 [28]. H28 contains a homozygous deletion of the β-catenin gene, making it useful in studying cellular processes involving β-catenin [28] [29]. Since these cells have no endogenous β-catenin expression, we reasoned that the surface expression of HSlo would be hindered. When H28 cells were transfected with the HSlo construct, very little surface expression of HSlo was observed (Figure 5C). However, when H28 cells were co-transfected with HSlo and an EGFP-tagged β-catenin, high HSlo surface expression was observed only in cells with high-level β-catenin expression (Figure 5D). Thus the surface expression of HSlo is correlated with the amount of β-catenin expressed.
β-catenin co-immunoprecipitates with HSlo
The data presented up to this point clearly show the interaction between β-catenin and HSlo in the S10 region of HSlo is important for channel surface expression, and possibly also affecting channel stability. Lesage at al were unable to show a direct interaction between these proteins by immunoprecipitation in COS cells (although they were able to do so in whole brains) leading them to conclude that this interaction was indirect. We tested the binding between β-catenin and HSlo by purifying HSlo tagged with the FLAG epitope. We column-purified HSlo from HEK cell lysates using an anti-FLAG antibody. β-catenin was detected by western blotting in purified HSlo sample (Figure 6A). Conversely, we were able to detect a robust signal for HSlo in western blots of immunoprecipitates of β-catenin (Figure 6B). Together, these results are consistent with a stable interaction between β -catenin and HSlo.
We also tested for co-immunoprecipitation with the deletion mutant HSloΔS10. β-catenin immunoprecipitates from stable cells expressing the deletion construct showed reduced levels of HSlo (Figure 6B). Consistent with this observation we were unable to detect β-catenin in immunoprecipitates of HSlo in cells expressing mutant HSloΔS10. This would argue for a stable interaction between β-catenin and HSlo that is partially dependent on the participation of amino acids in the S10 region of HSlo.
Phosphorylation mutants in the S10 region affect expression patterns and channel kinetics
Our co-IP data indicates that the mechanism of the interaction of HSlo with β-catenin through the S10 region and its significance in HSlo surface expression may lie in a simple binding between these two proteins. However, other factors may modulate this interaction or its physiological consequences. For instance, there are two potential GSK phosphorylation sites in the S10 region that contain the consensus GSK phosphorylation motif (SXXXS). A recent work attempting to identify putative phosphorylation sites in Slo determined these sites to have a high probability of phosphorylation based on two phospho-prediction algorithms [30]. These sites were however not accessible to liquid chromatography tandem mass spectrometry analysis [30]. Since they are in the S10 region, we sought to determine if these putative phosphorylation sites affect the surface expression of HSlo. To test this possibility we substituted the two serine residues S918 and S922 with alanine (S10AA) to mimic a constitutively dephosphorylated state. A second construct was made where these two serine residues were substituted with aspartate (S10DD) to mimic a constitutively phosphorylated state. Monoclonal stable cell lines made with these two respective constructs that have good HSlo expression, as assayed by western blotting, were chosen for further study.
The surface expression of the S10AA mutant is markedly reduced compared with the S10DD construct, which shows an increased level of surface expression of HSlo (Figure 7). In permeabilized cells, both had similar amount of intracellular labeling of HSlo, although the intracellular distribution of Slo differed. The internal Slo expression is less in S10DD mutant, while S10AA mutant has more intracellular retention (arrows in Figure 7C). We quantified the surface labeling in FACS experiments. Surface expression of the S10AA mutant was lower than wt HSlo. In contrast, the S10DD mutant had the highest amounts of HSlo relative surface expression as determined by the ratio of surface to total labeled HSlo.
We also analyzed the effects of the phosphomutants on HSlo channel activity, using macropatch recordings in the inside-out configuration. Two effects were evident. First, these mutations have an effect on the activation kinetics of the channel. In response to depolarizing steps the phosphomimetic form of the channel S10DD consistently activates more rapidly than the wildtype HSlo (Fig. 8A and 8B), irrespective of the concentration of internal Ca2+ (0 and 10 µM). In contrast, the phosphodeletion form of HSlo (S10AA) activated more slowly (Fig. 8A and 8B).
These mutations also have an effect on the steady-state Ca2+ and voltage sensitivities of the channel (Fig. 8C). At nominally zero Ca2+, the G-V curve of the phospho-mimetic form S10DD was left-shifted compared to wt Slo, while the phospho-deletion mimetic was right-shifted, requiring larger depolarization for channel opening. However, with 10 µM internal Ca2+ both mutant channels showed right-shifted G-V curves.
HSlo expression inhibits Wnt signaling in TOP Flash assays
Our data show that the interaction between β-catenin and Hslo affects channel surface expression, and that mutations of putative GSK phosphorylation sites in the S10 interaction domain in HSlo change both surface expression and channel kinetics. Since both β-catenin and GSK are involved in the canonical Wnt pathway [31], we speculate that the interaction between β-catenin and HSlo may also affect Wnt signaling. We therefore tested whether HSlo expression could influence β-catenin signaling through the Wnt pathway.
For these experiments we used the TOP-Flash assay to quantify Wnt signaling [32] We used transfection with either a β-catenin plasmid or with the Wnt 3a plasmid in Wnt 3a-sensitive 293T cells to induce Wnt signaling. In these cells a TCF-LEF promoter controls the expression of the downstream luciferase gene. Exogenous β-catenin, or free cytosolic β-catenin stimulated by expression of exogenous Wnt3a ligand, binds to TCF/LEF and activates luciferase transcription.
After establishing the amount of each plasmid needed to produce a sensitive assay, we settled on 0.05 µg Wnt3a or 0.7 µg β-catenin plasmid DNA per well in a 12 well plate. Wnt signaling intensity was assessed by measuring the activity of luciferase [33] [34]. Cells were then co-transfected with increasing concentrations of HSlo plasmid. As shown in Figure 9A, HSlo expression inhibited both Wnt and β-catenin driven signaling in a similar dose-dependent manner. The inhibitory effect on Wnt-signaling was monitored by using p200 as a positive control. p200 is part of the C-terminus of the polycystin-1 protein, and is known to specifically inhibit the binding between TCF-LEF and β-catenin, thus inhibiting the luciferase signal in the TOP-Flash assay [35]. In both assays, about 1.0 µg Slo plasmid per well produces 50% inhibition of signaling. This indicates that while β-catenin affects HSlo surface expression, HSlo expression can also modulate Wnt signaling.
We also tested the effects of various HSlo mutants on Wnt signaling (Figure 9B). Surprisingly, all these mutants have inhibitory effects similar to that of the wild type, even though their channel expression varies significantly (see Figures 2, 7).
HSlo - β-catenin interaction involves multiple sites on HSlo
The complex behavior of HSlo mutants in TOP-FLASH assays indicates a complexity in HSlo interaction with β-catenin. The fact that the S10 deletion mutant and two phosphorylation mutants behave similarly to wild type HSlo in inhibiting Wnt signaling points to the possibility of multiple modes of interaction between HSlo and β-catenin. One possible explanation for the seemingly incongruent data is that HSlo interacts with β-catenin in regions outside the S10 region. Therefore we set out to ascertain regions of interaction in HSlo with beta catenin using a peptide array. Overlapping 15-mer peptides of the entire C-terminus of HSlo starting from the linker region with the amino acid sequence VFFILG. were imprinted on an array and probed with purified, GST tagged β-catenin. Out of the total of 101 peptides used, twelve segments of the HSlo C-terminus, including the S10 region, were found to have high binding scores (Figures S2 and S3). Each of these segments contains surface-exposed residues according to the crystal structure of the C-terminal segment of Slo. [36]. Figure 10B shows the location of the S10 region and one of these segments beginning at E562, in the structure of the HSlo C-terminus. The location of these peptides on the surface of the protein is consistent with their ability to interact with other proteins.
In order to further validate the importance of these peptides in interactions with β-catenin we chose three peptide segments for further study (Figure 10A). The first 23 amino acid peptide beginning at residue D1014 (DRCR…DGGC) lies after the S10 region, near the caveolin binding site. The second 38 amino acid peptide beginning at residue E562 (EDT…LCFV) lies near the αH and βG region of RCK1 that have been shown to give rise to intracellular charibdotoxin sensitivity. A third 23 amino acid peptide beginning at residue D410 (DDVN…EALF) lies near the beginning of RCK1 region. We also used a hydrophilic 25 amino acid peptide from the extracellular protein acetycholinesterase as a negative control (AchE). This peptide has a high fraction of charged amino acids (10/23) and was used as a control since interactions with the armadillo repeats in β-catenin are thought to be mediated by charged residues – the armadillo repeats were shown to be the regions on β-catenin that interacted with HSlo. These four peptides were used in an in vitro competitive binding assay to test the efficacy of HSlo binding to β-catenin. Immobilized β-catenin was incubated with whole cell lysates of HSlo expressing HEK cells in the presence of these peptides. As shown in Figure 10B and 10C, the peptide beginning at residue E562 has significant inhibitory effects on HSlo binding to β-catenin. This confirms that there are sites on HSlo, outside the S10 region, that can interact with β-catenin. Moreover, since we used highly purified β-catenin and peptide arrays in these experiments, these data strongly suggest that the interaction between the two proteins to be direct.
Discussion
Several lines of evidence show that β-catenin plays an important role in the surface expression of Slo channels. Exogenously expressed Slo channels are co-localized with β-catenin in HEK cells, and deletion of the Slo S10 region, previously reported to bind to β-catenin, result in decreased surface expression of Slo. Moreover, knocking down β-catenin in HEK cells results in reduced HSlo surface expression. Consistent with these data and confirming a physiological consequence to the interaction, we show that knockdown of β-catenin results in a substantial reduction in Slo clusters on the surface of hair cells in the auditory epithelium of the chick. Furthermore, in the H28 cell line lacking β-catenin, the co-transfection of HSlo and β-catenin together results in greatly increased surface expression of HSlo. The interaction with HSlo represents the first instance in which β-catenin has been shown to increase the surface expression of a protein uninvolved in cell adhesion.
Alongside the effects on surface expression of Slo channel, we also have evidence that the interaction between β-catenin and Slo may stabilize the Slo channel and protect it from proteolytic degradation. For instance, transfection with β-catenin siRNA decreases the total amount of HSlo expressed in HSlo HEK cells, as detected by western blots of cell lysates. In chick cochlea treated with β-catenin siRNA, there was a decrease in total Slo expression. Moreover, in screening S10 deletion mutants, we detected significantly more HSlo fragments in all the HSloΔS10-HEK cell lines compared to the wt HSlo under the same conditions (Figure S1). This may be due to loss of protection conferred by β-catenin binding to HSlo, causing the mutant channel protein become less stable and more prone to proteolytic degradation. Alternatively it is possible that other structural changes in this HSlo mutant causes increased exposure to proteases. Further experiments are needed to clarify this.
Does β-catenin exert its effects through a direct interaction with the HSlo potassium channel subunit? Lesage et al. [16] showed that β-catenin can be co-purified with the chicken Slo protein from whole brain lysates, although not from heterologous expression systems. The latter result led these authors to speculate that the interaction between the two proteins was in fact indirect. However, our data suggest that the interaction between the two proteins is direct. We were able to demonstrate direct binding of highly purified β-catenin (99%) and peptide fragments of HSlo. In this context, the failure by Lesage et al. to demonstrate interactions between these proteins using an immunoprecipitation assay in COS cells might be related to the detergents used. They used 1% Triton-X 100 to solubilize cell membranes while we used 0.5% n-dodecyl β-D-maltoside (DDM) in our successful reciprocal immunoprecipitations.
In yeast two-hybrid experiments [16] it was shown that the interaction between Slo and β-catenin was limited to the S10 region. We find that deletion of the S10 region reduces the cell-surface expression of HSlo. Consistent with this result, reverse coimmunoprecipitation experiments show reduced association of the S10 deletion mutant with β-catenin. This supports the notion that reduction in surface expression of the deletion mutants arises partially from decreased β-catenin binding. Since the association was not completely lost with HSloΔS10 in co-IP experiments, the possibility is raised that HSlo interactions with β-catenin may extend to regions outside the S10 region. It is known that yeast two-hybrid experiments can fail to indentify regions of interaction between proteins. Indeed, our HSlo peptide array experiments identified 10 more sites on HSlo that potentially binds to β-catenin. Furthermore, our in vitro competitive binding experiments confirm that at least one of the possible sites outside S10, namely the 38 residue sequence beginning at residue E562, significantly reduces HSlo binding to immobilized β-catenin.
We identified two potential GSK phosphorylation sites within the S10 region. In addition to changing surface expression, phosphomimetic mutations at these sites affect channel kinetics and steady state voltage activation. At nominally 0 µM Ca2+, phosphomimetic and phosphodeletional mutations produce a hyperpolarizing and depolarizing shift in G-V curves respectively. However, at 10 µM Ca2+, the steady state voltage activation of both mutants is right-shifted compared to the wt channel. It is unclear how these effects might arise, but they are interesting in view of the fact that in the primary sequence the S10 region is adjacent to the Ca2+ binding site.
While our data suggest that phosphorylation of the two GSK3 phosphorylation sites in the S10 region have physiological importance, direct evidence of their phosphorylation is lacking. A recent mass spectroscopy analysis of Slo from rat brain categorized the phosphorylation status of these two residues as indeterminate [30]. In this context we have found variable effects on Slo surface expression using GSK3 phosphorylation inhibitors. GSK3 inhibitors variably increase and decrease relative surface expression of Slo. Since GSK3 phosphorylation also decreases β-catenin levels [37], [38], [39], [40], an indirect effect of increasing GSK activity would be predicted to decrease Slo surface expression. Thus, increased GSK3 activity would be predicted to have paradoxical effects on Slo surface expression with direct phosphorylation of Slo increasing Slo surface expression, and indirectly, via phosphorylation of β-catenin, decreasing Slo surface expression. The use of GSK3 inhibitors variably increasing and decreasing Slo surface expression is consistent with the paradoxical direct and indirect effect of GSK3 activity. In the absence of physical evidence of phosphorylation, these data are the best evidence of direct phosphorylation of Slo in-vivo.
Similarly, while our data show clear physiological effects of HSlo interactions with β-catenin on the one hand increasing HSlo surface expression and on the other hand decreasing Wnt signaling, we do not have a satisfactory explanation for the seeming discordance between the observed physiological effects of the interaction between these proteins and their physical interaction. Thus, while the phosphomimetic and phosphodeletional forms have differences in surface expression, immunoprecipitations do not show a difference in the strength of their interaction with β-catenin (data not shown). Conversely, we do not observe differences in Wnt signaling between HSlo and the S10 deletional form, even though immunoprecipitations suggest a clear difference in interaction strength. To be sure any number of reasons could explain these seemingly discordant results. These include differences in threshold between the functional assays and immunoprecipitation assays, allosteric effects on β-catenin's transcriptional activity mediated by regions of HSlo outside the S10 region, functional effects between the two proteins additionally mediated by a third protein etc. Irrespective of the exact mechanisms that underlie these phenomena that must await future exploration, these data point to a complex and dynamic interaction between HSlo and β-catenin.
It is widely recognized that β-catenin has a dual cellular function and involved in cell adhesion and, separately, is integral to the developmentally important Wnt signaling pathway. Using a transcriptional assay we find a dose-dependent inhibition of Wnt signaling by HSlo expression. Wnt signaling induced either by expression of the Wnt3a ligand or by overexpression of β-catenin is suppressed as the expression of HSlo is increased. This effect is likely due to HSlo interactions with β-catenin, which may in turn reduce the size of the free pool of β-catenin available for activating Wnt signaling. It is unlikely that HSlo expression led to increased degradation of β-catenin, since the levels of total β-catenin were invariant irrespective of the mutants of HSlo transfected (Fig. 9B).
The observation that HSlo affects Wnt signaling has substantial implications. It is one of the first instances where the expression of an ion channel has been shown to affect signaling possibly independent of its effects on ionic flux. One instance where this has been previously shown is the ability of the Drosophila Eag channel to bind and activate Ca2+-calmodulin-dependent protein kinase II (CaMKII), independent of calmodulin and autophosphorylation [41]. Similarly, Wnt signaling by β-catenin is also down-regulated by the C-terminus of the transmembrane protein polycystin-1, which associates closely with the TRP channel polycystin-2 [35]. Future experiments will be required to determine whether HSlo plays a physiologically important role as a regulator of Wnt signaling in vivo. This is particularly the case since Wnt signaling affects planer cell polarity of hair cells, and since Slo is restricted to the basolateral pole of hair cells.
In conclusion, we extend previous work showing interactions between the S10 region of Slo and β-catenin. In particular we elucidate the physiological significance of this interaction. We show that this interaction is important for surface expression of HSlo, and may be also important for the stability of Slo channel. The binding of these two proteins extends to regions outside the S10 region, as HSlo reversibly precipitates β-catenin in co-IP experiments, while S10 deletion mutant channels have reduced, but not absent, binding to β-catenin. This possibility was confirmed by β-catenin binding to multiple Hslo peptides in a peptide array. Possible phosphorylation by GSK3 on S10 region of HSlo, and the Ca2+-binding states of the channel may also affect this interaction, since mutations on the putative phosphorylation sites in the S10 region alters channel activation kinetics and steady state voltage and Ca2+ sensitivity. In addition to the effect of β-catenin on Slo channel surface expression, our data show that HSlo overexpression also affects canonical β-catenin-dependent Wnt signaling pathway. The expression of HSlo can, in a dose dependent manner, inhibit Wnt signaling in TOP-Flash assays. This is among the first in a growing literature demonstrating direct effects on Wnt signaling by ion channels.
Supporting Information
Acknowledgments
The authors thank Dr. Edward Moczydlowski (Clarkson University) for valuable discussions in the beginning of the project, and for providing the rabbit anti BsloC antibody. Dr. Joseph Schlesinger kindly provided access to his Nikon TE-2000E microscope. Dr. Mary Tomayko helped in doing FACS experiments.
Footnotes
Competing Interests: The authors have declared that no competing interests exist.
Funding: This work was supported by National Institutes of Health grants NS21501 to FJS and R01 DC007894 to DSN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Salkoff L, Butler A, Ferreira G, Santi C, Wei A. High-conductance potassium channels of the SLO family. Nat Rev Neurosci. 2006;7:921–931. doi: 10.1038/nrn1992. [DOI] [PubMed] [Google Scholar]
- 2.Ledoux J, Werner ME, Brayden JE, Nelson MT. Calcium-activated potassium channels and the regulation of vascular tone. Physiology (Bethesda) 2006;21:69–78. doi: 10.1152/physiol.00040.2005. [DOI] [PubMed] [Google Scholar]
- 3.Grimm PR, Sansom SC. BK channels in the kidney. Curr Opin Nephrol Hypertens. 2007;16:430–436. doi: 10.1097/MNH.0b013e32826fbc7d. [DOI] [PubMed] [Google Scholar]
- 4.Cui J, Aldrich RW. Allosteric linkage between voltage and Ca(2+)-dependent activation of BK-type mslo1 K(+) channels.[erratum appears in Biochemistry 2001 May 22;40(20):6190]. Biochemistry. 2000;39:15612–15619. doi: 10.1021/bi001509+. [DOI] [PubMed] [Google Scholar]
- 5.Atkinson NS, Robertson GA, Ganetzky B. A component of calcium-activated potassium channels encoded by the Drosophila slo locus. Science. 1991;253:551–555. doi: 10.1126/science.1857984. [DOI] [PubMed] [Google Scholar]
- 6.Butler A, Tsunoda S, McCobb DP, Wei A, Salkoff L. mSlo, a complex mouse gene encoding “maxi” calcium-activated potassium channels. Science. 1993;261:221–224. doi: 10.1126/science.7687074. [DOI] [PubMed] [Google Scholar]
- 7.Latorre R, Brauchi S. Large conductance Ca2+-activated K+ (BK) channel: activation by Ca2+ and voltage. Biol Res. 2006;39:385–401. doi: 10.4067/s0716-97602006000300003. [DOI] [PubMed] [Google Scholar]
- 8.Lu R, Alioua A, Kumar Y, Eghbali M, Stefani E, et al. MaxiK channel partners: physiological impact. J Physiol. 2006;570:65–72. doi: 10.1113/jphysiol.2005.098913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Torres YP, Morera FJ, Carvacho I, Latorre R. A marriage of convenience: beta-subunits and voltage-dependent K+ channels. J Biol Chem. 2007;282:24485–24489. doi: 10.1074/jbc.R700022200. [DOI] [PubMed] [Google Scholar]
- 10.Jo S, Lee KH, Song S, Jung YK, Park CS. Identification and functional characterization of cereblon as a binding protein for large-conductance calcium-activated potassium channel in rat brain. J Neurochem. 2005;94:1212–1224. doi: 10.1111/j.1471-4159.2005.03344.x. [DOI] [PubMed] [Google Scholar]
- 11.Cox EA, Bennin D, Doan AT, O'Toole T, Huttenlocher A. RACK1 regulates integrin-mediated adhesion, protrusion, and chemotactic cell migration via its Src-binding site. Molecular Biology of the Cell. 2003;14:658–669. doi: 10.1091/mbc.E02-03-0142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Tian L, Chen L, McClafferty H, Sailer CA, Ruth P, et al. A noncanonical SH3 domain binding motif links BK channels to the actin cytoskeleton via the SH3 adapter cortactin. Faseb J. 2006;20:2588–2590. doi: 10.1096/fj.06-6152fje. [DOI] [PubMed] [Google Scholar]
- 13.Alioua A, Lu R, Kumar Y, Eghbali M, Kundu P, et al. Slo1 caveolin-binding motif, a mechanism of caveolin-1-Slo1 interaction regulating Slo1 surface expression. J Biol Chem. 2008;283:4808–4817. doi: 10.1074/jbc.M709802200. [DOI] [PubMed] [Google Scholar]
- 14.Lim HH, Park CS. Identification and functional characterization of ankyrin-repeat family protein ANKRA as a protein interacting with BKCa channel. Mol Biol Cell. 2005;16:1013–1025. doi: 10.1091/mbc.E04-06-0537. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Ling S, Sheng J-Z, Braun JEA, Braun AP. Syntaxin 1A co-associates with native rat brain and cloned large conductance, calcium-activated potassium channels in situ. J Physiol (Lond) 2003;553:65–81. doi: 10.1113/jphysiol.2003.051631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Lesage F, Hibino H, Hudspeth AJ. Association of beta-catenin with the alpha-subunit of neuronal large-conductance Ca2+-activated K+ channels. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:671–675. doi: 10.1073/pnas.0307681100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science. 2004;303:1483–1487. doi: 10.1126/science.1094291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Butz S, Okamoto M, Sudhof TC. A tripartite protein complex with the potential to couple synaptic vesicle exocytosis to cell adhesion in brain. Cell. 1998;94:773–782. doi: 10.1016/s0092-8674(00)81736-5. [DOI] [PubMed] [Google Scholar]
- 19.Maximov A, Sudhof TC, Bezprozvanny I. Association of neuronal calcium channels with modular adaptor proteins. J Biol Chem. 1999;274:24453–24456. doi: 10.1074/jbc.274.35.24453. [DOI] [PubMed] [Google Scholar]
- 20.Perego C, Vanoni C, Massari S, Longhi R, Pietrini G. Mammalian LIN-7 PDZ proteins associate with beta-catenin at the cell-cell junctions of epithelia and neurons. EMBO J. 2000;19:3978–3989. doi: 10.1093/emboj/19.15.3978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Usami N, Sekido Y, Maeda O, Yamamoto K, Minna JD, et al. Beta-catenin inhibits cell growth of a malignant mesothelioma cell line, NCI-H28, with a 3p21.3 homozygous deletion. Oncogene. 2003;22:7923–7930. doi: 10.1038/sj.onc.1206533. [DOI] [PubMed] [Google Scholar]
- 22.Bingham JP, Bian S, Tan ZY, Takacs Z, Moczydlowski E. Synthesis of a biotin derivative of iberiotoxin: binding interactions with streptavidin and the BK Ca2+-activated K+ channel expressed in a human cell line. Bioconjug Chem. 2006;17:689–699. doi: 10.1021/bc060002u. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Wallner M, Meera P, Ottolia M, Kaczorowski GJ, Latorre R, et al. Characterization of and modulation by a beta-subunit of a human maxi KCa channel cloned from myometrium. Receptors Channels. 1995;3:185–199. [PubMed] [Google Scholar]
- 24.Samaranayake H, Saunders JC, Greene MI, Navaratnam DS. Ca(2+) and K(+) (BK) channels in chick hair cells are clustered and colocalized with apical-basal and tonotopic gradients. J Physiol. 2004;560:13–20. doi: 10.1113/jphysiol.2004.069856. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Frucht CS, Uduman M, Duke JL, Kleinstein SH, Santos-Sacchi J, et al. Gene expression analysis of forskolin treated basilar papillae identifies microRNA181a as a mediator of proliferation. PLoS One. 2010;5:e11502. doi: 10.1371/journal.pone.0011502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85–100. doi: 10.1007/BF00656997. [DOI] [PubMed] [Google Scholar]
- 28.Shigemitsu K, Sekido Y, Usami N, Mori S, Sato M, et al. Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion. Oncogene. 2001;20:4249–4257. doi: 10.1038/sj.onc.1204557. [DOI] [PubMed] [Google Scholar]
- 29.Maeda O, Usami N, Kondo M, Takahashi M, Goto H, et al. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line. Oncogene. 2004;23:964–972. doi: 10.1038/sj.onc.1207254. [DOI] [PubMed] [Google Scholar]
- 30.Yan J, Olsen JV, Park KS, Li W, Bildl W, et al. Profiling the phospho-status of the BKca channel a subunit in rat brain reveals unexpected patterns and complexity. Mol Cell Proteomics. 2008 doi: 10.1074/mcp.M800063-MCP200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Jin T, George Fantus I, Sun J. Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin. Cell Signal. 2008;20:1697–1704. doi: 10.1016/j.cellsig.2008.04.014. [DOI] [PubMed] [Google Scholar]
- 32.Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ. Exosome release of beta-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol. 2010;190:1079–1091. doi: 10.1083/jcb.201002049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC−/− colon carcinoma. Science. 1997;275:1784–1787. doi: 10.1126/science.275.5307.1784. [DOI] [PubMed] [Google Scholar]
- 34.DasGupta R, Kaykas A, Moon RT, Perrimon N. Functional genomic analysis of the Wnt-wingless signaling pathway. Science. 2005;308:826–833. doi: 10.1126/science.1109374. [DOI] [PubMed] [Google Scholar]
- 35.Lal M, Song X, Pluznick JL, Giovanni VD, David MMerrick, et al. Polycystin-1 C-terminal tail associates with b-catenin and inhibits canonical Wnt signaling. Human Molecular Genetics. 2008;17 doi: 10.1093/hmg/ddn208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Yuan P, Leonetti MD, Pico AR, Hsiung Y, MacKinnon R. Structure of the human BK channel Ca2+-activation apparatus at 3.0 A resolution. Science. 2010;329:182–186. doi: 10.1126/science.1190414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Yost C, Torres M, Miller JR, Huang E, Kimelman D, et al. The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev. 1996;10:1443–1454. doi: 10.1101/gad.10.12.1443. [DOI] [PubMed] [Google Scholar]
- 38.Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol. 1998;8:573–581. doi: 10.1016/s0960-9822(98)70226-x. [DOI] [PubMed] [Google Scholar]
- 39.Salic A, Lee E, Mayer L, Kirschner MW. Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the Wnt pathway in Xenopus egg extracts. Mol Cell. 2000;5:523–532. doi: 10.1016/s1097-2765(00)80446-3. [DOI] [PubMed] [Google Scholar]
- 40.Wu D, Pan W. GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem Sci. 2010;35:161–168. doi: 10.1016/j.tibs.2009.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Sun XX, Hodge JJ, Zhou Y, Nguyen M, Griffith LC. The eag potassium channel binds and locally activates calcium/calmodulin-dependent protein kinase II. J Biol Chem. 2004;279:10206–10214. doi: 10.1074/jbc.M310728200. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.